Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats

Experimental Neurology

Volumn 159, Issue 2, 1999, Pages 551-558

  Tredici, Giovanni ^a   Braga, Massimiliano ^a   Nicolini, Gabriella ^a   Miloso, Mariarosaria ^a   Marmiroli, Paola ^a   Schenone, Angelo ^b   Nobbio, Lucilla ^b   Frattola, Lodovico ^a,c   Cavaletti, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cisplatin; Nerve growth factor; Neurophysiology; Neuroprotection; Pathology; Peripheral neuropathy

Indexed keywords

CISPLATIN; RECOMBINANT NERVE GROWTH FACTOR;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; NERVE CONDUCTION; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NEUROPATHY; SPINAL GANGLION;

EID: 0032874159     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7174     Document Type: Article

References (52)

1. Apfel S. C., Arezzo J. C., Lipson L. A., Kessler J. A. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 31:1992;76-80.
2. Apfel S. C., Kessler J. A. Neurotrophic factors in the treatment of peripheral neuropathy. Ciba Found. Symp. 196:1996;98-108.
3. Apfel S. C., Kessler J. A., Adornato B. T., Litchy W. J., Sanders C., Rask C. A. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. 51:1998;695-702.
4. Apfel S. C. Neurotrophic factors in peripheral neuropathies: therapeutical implications. Brain Pathol. 9:1999;393-413.
5. Barajon I., Bersani M., Quartu M., Del Fiacco M., Cavaletti G., Holst J. J., Tredici G. Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp. Neurol. 138:1996;93-104.
6. Barde Y. A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1:1982;549-553.
7. Cavaletti G., Tredici G., Marmiroli P., Petruccioli M. G., Barajon I., Fabbrica D. Morphometric study of the sensory neurones and peripheral nerve changes induced by chronic cisplatin (DDP) administration. Acta Neuropathol. 84:1992;364-371.
8. Cavaletti G., Minoia C., Schieppati M., Tredici G. Protective effects of glutathione on cisplatin neurotoxicity in rats. Int. J. Rad. Oncol. Biol. Phys. 29:1994;771-776.
9. Cavaletti G., Tredici G., Marmiroli P., Fabbrica D., Braga M. Off-treatment course of cisplatin-induced dorsal root ganglia neuronopathy in rats. In Vivo. 8:1994;313-316.
10. Cavaletti G., Cascinu S., Venturino P., Tedeschi M., Tredici G. Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res. 16:1996;3149-3159.
11. Cavaletti G., Tredici G. Evaluation of cisplatin neuroprotection. Ann. Neurol. 39:1996;827.
12. Cece R., Petruccioli M. G., Pizzini G., Cavaletti G., Tredici G. Ultrastructural aspects of DRG satellite cell involvement in experimental cisplatin neuronopathy. J. Submicr. Cytol. Pathol. 27:1995;417-425.
13. Conti A. M., Fisher S. J., Windebank A. J. Inhibition of axonal growth from sensory neurons by excess nerve growth factor. Ann. Neurol. 41:1997;838-846.
14. Cornblath D. R., Brown M. J. Influence of malnutrition on developing rat peripheral nerves. Exp. Neurol. 99:1988;403-411.
15. Eriksson N. P., Lindsay R. M., Alskogius H. BDNF and NT-3 rescue sensory but not motoneurons following axotomy in the neonate. NeuroReport. 5:1994;1445-1448.
16. Gao W.-Q., Dybdal N., Shinsky N., Murnane A., Schmelzer C., Siegel M., Keller G., Hefti F., Phillips H. S., Winslow J. W. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann. Neurol. 38:1995;30-37.
17. Geldof A. A. Nerve-growth-factor-dependent neurite outgrowth assay: A research model for chemotherapy-induced neuropathy. J. Cancer Res. Clin. Oncol. 121:1995;657-660.
18. Gill J. S., Windebank A. J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Inv. 101:1998;2842-2850.
19. Gold B. G., Mobley W. C., Matheson S. F. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J. Neurosci. 11:1991;943-955.
20. Hayakawa K., Soube G., Itoh T., Mitsuma T. Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol on adult rat sympathetic ganglion explants in vitro. Life Sci. 55:1994;519-525.
21. Hellweg R., Baethge C., Hartung H. D., Bruckner M. K., Arendt T. NGF level in the sciatic nerve is decreased after long-term consumption of ethanol. NeuroReport. 7:1996;777-780.
22. Hohn A., Leibrock J., Bailey K., Barde Y. A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 344:1990;339-341.
23. Kokaia Z., Bengzon J., Metsis M., Kokaia K., Persson H., Lindvall O. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc. Natl. Acad. Sci. USA. 90:1993;6711-6715.
24. Kokaia Z., Metsis M., Kokaia M., Elmer E., Lindvall O. Co-expression of TrkB and TrkC receptors suggests regulation by multiple neurotrophins. NeuroReport. 6:1995;769-772.
25. Konings P. N. M., Makkink W. K., van Delft A. M. L., Ruigt G. S. F. Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro. Brain Res. 640:1994;195-204.
26. Leibrok J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski H., Thoenen H., Barde Y. A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
27. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
28. Lewin G. R., Mendell L. M. Nerve growth factor and nociception. Trends Neurosci. 16:1993;353-359.
29. Lewin G. R., Barde Y. A. Physiology of the neurotrophins. Ann. Rev. Neurosci. 19:1996;289-317.
30. Lindsay R. M. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci. 8:1988;2394-2405.
31. Maisonpierre P. C., Belluscio L., Squinto S., Ip N., Furth M. E., Lindsay R. M., Yancopoulos G. D. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science. 247:1990;1446-1451.
32. Malgrange B., Delrée P., Rigo J. M., Baron H., Moonen G. Image analysis of neurite regeneration by adult rat dorsal root ganglion neurons in culture: Quantification of the neurotoxicity of anticancer agents and its prevention by nerve growth factor or fibroblast growth factor but not brain-derived neurotrophic factor or neurotrophin-3. J. Neurosci. Methods. 53:1994;111-122.
33. Meijer, C, E. G. E. de Vries, P. Marmiroli, G. Tredici, L. Frattola, and, G. Cavaletti, Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy, Neurotoxicology, (in press).
34. Mollman J. E. Cisplatin neurotoxicity. N. Engl. J. Med. 322:1990;126-127.
35. Pover C. M., Coggeshall R. E. Verification of the disector method for counting neurons, with comments on the empirical method. Anat. Rec. 231:1991;573-578.
36. 4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res. 676:1995;258-267.
37. Saita K., Ohi T., Hanaoka Y., Furukawa S., Furukawa Y., Hayashi K., Matsukura S. Effect of 4-methylcatecol, a stimulator of endogenous nerve growth factor synthesis, on experimental acrylamide-induced neuropathy in rats. Neurotoxicology. 16:1995;403-412.
38. Schmidt Y., Unger J. W., Bartke I., Reiter R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp. Neurol. 132:1995;16-23.
39. Sendtner M., Holtmann B., Kolbeck R., Thoenen H., Barde Y. A. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 360:1992;757-759.
40. Snider W. D. How do you feel? Neurotrophins and mechanotransduction. Nature Neurosci. 1:1998;5-6.
41. Terheggen P. M. A. B., Gerritsen van der Hoop R., Floot B. G. J., Gispen W. H. Cellular distribution of cis-Diamminedichloroplatinum(II)-DNA binding in rat dorsal root spinal ganglia: Effect of the neuroprotecting peptide ORG.2766. Toxicol. Appl. Pharmacol. 99:1989;334-343.
42. Tomiwa K. C., Nolan C., Cavanagh J. B. The effects of cisplatin on rat spinal ganglia: A study by light and electron microscopy and by morphometry. Acta Neuropathol. 69:1986;295-308.
43. Tomlinson D. R., Fernyhough P., Diemel L. T. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes. 46:1997;S43-49.
44. Tredici G., Cavaletti G., Petruccioli M. G., Fabbrica D., Tedeschi M., Venturino P. Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats. Neurotoxicology. 15:1994;701-704.
45. Tredici G., Cavaletti G., Nicolini G., Zoia C., Del Fiacco M., Quartu M., Nobbio L., Schenone A. Modulation of neurotrophins and their receptors in experimental cisplatin neuropathy. Eur. J. Histochem. 41:1997;11.
46. Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J. Neuroncol. 36:1998;31-40.
47. Verge V. M., Riopelle R. J., Richardson P. M. Nerve growth factor receptors on normal and injured sensory neurons. J. Neurosci. 9:1989;914-922.
48. Verge V. M., Merlio J. P., Grondin J., Ernfors P., Persson H., Riopelle R. J., Hokfelt T., Richardson P. M. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: Responses to injury and infusion of NGF. J. Neurosci. 12:1992;4011-4022.
49. Yan Q., Matheson C., Lopez O. T., Miller J. A. The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor. J. Neurosci. 14:1994;5281-5291.
50. Yuen E. C., Mobley W. C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:1996;346-354.
51. Windebank A. J. Neuronal growth factors in the peripheral nervous system. Dyck P. J., Thomas P. K., Griffin J. W., Low P. A., Podluso J. F. Peripheral Neuropathy. 1993;377-388 Saunders, Philadelphia.
52. Windebank A. J., Smith A. G., Russell J. W. The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology. 44:1994;488-494.